Carasent ASA 

kr14.33
16
+kr0.04+0.31% Friday 18:46

統計

當日最高
0
當日最低
0
52週最高
17.02
52週最低
0
成交量
0
平均成交量
546
市值
-
市盈率
0.32
股息收益率
12.84%
股息
1.84

即將到來

股息

12.84%股息收益率
10年增長
N/A
5年增長率
N/A
3年增長率
N/A
1年增長率
N/A

收益

24Oct預期
Q1 2023
Q2 2023
Q3 2023
Q4 2023
Q1 2024
Q2 2024
下一個
-0.04
-0
0.03
0.07
預期每股收益
0.071726278796856
實際每股收益
N/A

人們還關注

此列表基於在 Stock Events 上關注 0H9M.LSE 的人的關注列表。這不是投資建議。

競爭者

這個列表是基於最近市場事件的分析。這不是投資建議。

關於

Carasent ASA provides cloud based electronic health record solutions to the health care industry in Sweden, Norway, and internationally. The company offers Webdoc, a cloud-based EHR system; Metodika EPM, a solution designed for mid-to-large-sized organizations; Medrave M4 to give healthcare staff and managers an overview and clear picture of the patient group being treated; Health Profile Institute AB (HPI), an occupational care platform; Ad Curis, a record system with digital services tailored for the specialist healthcare service with clients in rehabilitation, interdisciplinary specialized drug treatment, and mental health care, as well as businesses in care and prevention; and Ad Opus, a journal system for follow-up of participants in measures. It also provides platform services, such as Vårdrummet, Confrere, Ad Voca, electronic letters, SMS services, portal to medical services, and consulting and other services. The company was formerly known as Apptix ASA and changed its name to Carasent ASA in May 2019. Carasent ASA was founded in 1997 and is based in Oslo, Norway.
Show more...
首席執行官
Mr. Niclas Hugosson
員工
165
國家
NO
ISIN
NO0010123060

上市公司